Case Study

Rolling Start-Up Key In Global Observational Cohort Study For Patients With Psoriasis

Chain Strategy Visibilty Map

UBC was selected by a large biopharmaceutical company to manage a 5 year (2 year enrollment, 3 year follow-up) observational cohort study for patients with moderate-severe psoriasis who are initiating or switching to a new biologic. The global study spanned 268 sites across 23 countries in North America, Latin America, Europe, Asia, Middle East, and Australia and included 3,200 patients in routine care setting. The observational study was designed to compare treatment effectiveness in three patient cohorts, each prescribed a specific biologic treatment in clinical practice, as well as to compare improvement in patientreported outcomes (PRO) across treatments.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: